1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Astrocytoma of Brain: new trials by email Literature Review of Astrocytoma of Brain trials Research Report on Astrocytoma of Brain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma Tislelizumab plus Bevacizumab - Astrocytoma of Brain | Phase 2 | Not yet recruiting | Henan Provincial People's Hospital | 70 | 2022-12-01 | 2022-09-27 |
Bevacizumab (1) · tislelizumab (1)
Henan Provincial People's Hospital (1)
China (1)
Xingyao Bu (1)